CLINICAL_TRIALS
trial_result
· 2018-08-20
Clinical Trial Update: Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI) [Phase 2]
Summary
Phase 2 clinical study update evaluating bivalirudin for percutaneous coronary intervention (PCI) in patients with coronary heart disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Qian Gong | Conditions: Coronary Heart Disease | Phase 2 | Status: UNKNOWN